RNS Number : 2349D

Elementis PLC

01 March 2022

1 March 2022

Elementis plc (the "Company") - Director declaration

In accordance with Listing Rule 9.6.14, the Company today confirms that Anne Hyland, one of its non-executive directors, has been appointed as a non-executive director of Mereo BioPharma Group Plc, a biopharmaceutical company developing and commercialising new therapies for oncology and rare diseases, which is listed on the NASDAQ exchange under MREO ticker.

Laura Higgins

Group Company Secretary

020 7067 2999

LEI: 549300LQIH685LI2ML36

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

March 01, 2022 09:03 ET (14:03 GMT)

Elementis (LSE:ELM)
Gráfica de Acción Histórica
De Dic 2022 a Ene 2023 Haga Click aquí para más Gráficas Elementis.
Elementis (LSE:ELM)
Gráfica de Acción Histórica
De Ene 2022 a Ene 2023 Haga Click aquí para más Gráficas Elementis.